Prevention of stroke in patients with atrial fibrillation: a role of modern anticoagulants

被引:0
|
作者
Anisimova, A. V. [1 ]
Gendlin, G. E.
Borisov, S. N.
机构
[1] Pirogov Russian Natl Res Med Univ, Moscow, Russia
关键词
cardioembolic stroke; atrial fibrillation; primary and secondary prevention; oral anticoagulant; warfarin; rivaroxaban; FACTOR XA INHIBITOR; RISK-FACTORS; RIVAROXABAN; WARFARIN; MANAGEMENT; APPENDAGE; SAFETY;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The review addresses the primary and secondary prevention of cardioembolic ischemic stroke, in particular, in patients with non-valvular atrial fibrillation. Indications and schemes of anticoagulation treatment, advantages in stroke prevention and difficulties in using of the common oral anticoagulant warfarin are discussed. The authors compare the mechanism of action, efficacy and safety of the peroral anticoagulant rivaroxaban with warfarin. Based on the results of large meta-analyses, it has been concluded that the efficacy of rivaroxaban is rather superior to warfarin, this drug has the same safety profile and is more convenient in use. During treatment, no laboratory monitoring of hemostasis indicators is needed. This drug can be recommended for prevention of cardioembolic stroke in patients with atrial fibrillation.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 50 条
  • [31] Uncovering the Role of Direct Oral Anticoagulants in Stroke Prevention for Atrial Fibrillation: A Review of the Literature
    Rao, Sudipta
    Aggarwal, Shailesh
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [32] Stroke prevention in atrial fibrillation. Old and new anticoagulants
    Darius, H.
    Sommer, S.
    HERZ, 2013, 38 (03) : 231 - +
  • [33] Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Comprehensive Review
    Perswani, Prinka
    Yogarajah, Ritesh Croos
    Saifuddin, Mohammed
    Lakhani, Alisha
    Dasi, Jagruti
    Bhardwaj, Vanshika
    Kumar, Bhavana
    Raina, Ojasvi
    Fletcher, Nicole
    Jomy, Grace
    Iyer, Pracruti
    Pasi, Jai
    Tayal, Kanika
    Reza, Hasim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [34] Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation
    Baker, D.
    Wilsmore, B.
    Narasimhan, S.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (07) : 792 - 797
  • [35] Stroke Prevention in Atrial Fibrillation: Impact of Novel Oral Anticoagulants
    Haft, Jacob I.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (03) : 241 - 248
  • [36] Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
    Kansal, Anuraag R.
    Zheng, Ying
    Pokora, Tiffany
    Sorensen, Sonja V.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 225 - 237
  • [37] Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation
    Oertel, Lynn B.
    Fogerty, Annemarie E.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2017, 29 (09) : 551 - 561
  • [38] Direct Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
    Jain, Vardhmaan
    Bhatia, Kirtipal
    Aggarwal, Devika
    Bansal, Agam
    Narasimhan, Bharat
    Hendrickson, Michael J.
    Arora, Sameer
    Ricciardi, Mark J.
    Qamar, Arman
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2021, 5 (06): : 631 - 633
  • [39] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [40] Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
    Nazeri, Alireza
    TEXAS HEART INSTITUTE JOURNAL, 2018, 45 (03) : 164 - 165